ONCOMATRYX

Healthcare & Life Sciences

Recent Finacing

Equity

Recent Raise

$26.2M

ONCOMATRYX is a biopharmaceutical company developing novel Antibody-Drug Conjugates targeting the tumor microenvironment to treat metastatic solid tumors.